Acute myeloid leukemia as an adverse event in a patient treated with a poly(ADP-ribose) polymerase (PARP) inhibitor. Girard S, Lours C. Am J Hematol 2023 May 25. doi: 10.1002/ajh.26969.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Girard S, Lours C. Acute myeloid leukemia as an adverse event in a patient treated with a poly(ADP-ribose) polymerase (PARP) inhibitor. Am J Hematol 2023 May 25. doi: 10.1002/ajh.26969.
PMID: 37226864